A carregar...
Blockade of CDK7 Reverses Endocrine Therapy Resistance in Breast Cancer
Cyclin-dependent kinase (CDK)-7 inhibitors are emerging as promising drugs for the treatment of different types of cancer that show chemotherapy resistance. Evaluation of the effects of CDK7 inhibitor, THZ1, alone and combined with tamoxifen is of paramount importance. Thus, in the current work, we...
Na minha lista:
| Publicado no: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7215326/ https://ncbi.nlm.nih.gov/pubmed/32340192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21082974 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|